Skip to main content
Sonal Bhatia, MD, Child Neurology, Charleston, SC

SonalBhatiaMD

Child Neurology Charleston, SC

Epilepsy

Assistant Professor

Dr. Bhatia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bhatia's full profile

Already have an account?

  • Office

    125 Doughty St
    Roper Medical Office Building
    Charleston, SC 29403

Education & Training

  • Topiwala National Medical College
    Topiwala National Medical CollegeClass of 2005
  • Medical University of South Carolina
    Medical University of South CarolinaResidency, Child Neurology
  • Medical University of South Carolina
    Medical University of South CarolinaFellowship, Epilepsy

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2024 - 2027
  • NY State Medical License
    NY State Medical License 2005 - 2026
  • TX State Medical License
    TX State Medical License 2023 - 2026
  • UT State Medical License
    UT State Medical License 2023 - 2026
  • AZ State Medical License
    AZ State Medical License 2023 - 2025
  • CO State Medical License
    CO State Medical License 2023 - 2025
  • GA State Medical License
    GA State Medical License 2023 - 2025
  • American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
  • American Board of Psychiatry and Neurology Epilepsy
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual Meeting
    Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual MeetingNovember 3rd, 2023
  • Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
    Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia BApril 30th, 2024
  • FDA Approves CDx to Determine Gene Therapy Eligibility for Hemophilia B Patients
    FDA Approves CDx to Determine Gene Therapy Eligibility for Hemophilia B PatientsApril 30th, 2024